1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Arnold M, Abnet CC, Neale RE, Vignat J,
Giovannucci EL, McGlynn KA and Bray F: Global burden of 5 major
types of gastrointestinal cancer. Gastroenterology.
159:335–349.e15. 2020. View Article : Google Scholar : PubMed/NCBI
|
3
|
Chen R, Zheng R, Zhang S, Wang S, Sun K,
Zeng H, Li L, Wei W and He J: Patterns and trends in esophageal
cancer incidence and mortality in China: An analysis based on
cancer registry data. J National Cancer Center. 3:21–27. 2023.
View Article : Google Scholar
|
4
|
Ajani JA, D'Amico TA, Almhanna K, Bentrem
DJ, Besh S, Chao J, Das P, Denlinger C, Fanta P, Fuchs CS, et al:
Esophageal and esophagogastric junction cancers, version 1.2015. J
Natl Compr Canc Netw. 13:194–227. 2015. View Article : Google Scholar : PubMed/NCBI
|
5
|
Yan X, Duan H, Ni Y, Zhou Y, Wang X, Qi H,
Gong L, Liu H, Tian F, Lu Q, et al: Tislelizumab combined with
chemotherapy as neoadjuvant therapy for surgically resectable
esophageal cancer: A prospective, single-arm, phase II study
(TD-NICE). Int J Surg. 103:1066802022. View Article : Google Scholar : PubMed/NCBI
|
6
|
Wang H, Jiang Z, Wang Q, Wu T, Guo F, Xu
Z, Yang W, Yang S, Feng S, Wang X, et al: Pathological response and
prognostic factors of neoadjuvant PD-1 blockade combined with
chemotherapy in resectable oesophageal squamous cell carcinoma. Eur
J Cancer. 186:196–210. 2023. View Article : Google Scholar : PubMed/NCBI
|
7
|
Gao L, Lu J, Zhang P, Hong ZN and Kang M:
Toripalimab combined with docetaxel and cisplatin neoadjuvant
therapy for locally advanced esophageal squamous cell carcinoma: A
single-center, single-arm clinical trial (ESONICT-2). J
Gastrointest Oncol. 13:478–487. 2022. View Article : Google Scholar : PubMed/NCBI
|
8
|
Abdallah N, Nagasaka M, Abdulfatah E, Shi
D, Wozniak AJ and Sukari A: Non-small cell to small cell lung
cancer on PD-1 inhibitors: Two cases on potential histologic
transformation. Lung Cancer (Auckl). 9:85–90. 2018.PubMed/NCBI
|
9
|
Sehgal K, Varkaris A, Viray H, VanderLaan
PA, Rangachari D and Costa DB: Small cell transformation of
non-small cell lung cancer on immune checkpoint inhibitors:
Uncommon or under-recognized? J Immunother Cancer. 8:e0006972020.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Shah MH, Goldner WS, Benson AB, Bergsland
E, Blaszkowsky LS, Brock P, Chan J, Das S, Dickson PV, Fanta P, et
al: Neuroendocrine and adrenal tumors, version 2.2021, NCCN
clinical practice guidelines in oncology. J Natl Compr Canc Netw.
19:839–868. 2021. View Article : Google Scholar : PubMed/NCBI
|
11
|
Thomas WR, David K, Eugene HB, Hemant I,
Deepa TP, Adam JB, Jeremy JE, Hans G and L.H W: AJCC Cancer Staging
Manual. 8th edition. Springer; New York, NY: 2017
|
12
|
Odze RD, Lam AK and A O: WHO
Classification of Tumors: Digestive System Tumours. 5th edition.
IARC Press; Lyon: 2019
|
13
|
Zheng R, Zhang S, Zeng H, Wang S, Sun K,
Chen R, Li L, Wei W and He J: Cancer incidence and mortality in
China, 2016. J National Canc Center. 2:1–9. 2022. View Article : Google Scholar
|
14
|
Imakita T, Fujita K, Kanai O, Terashima T
and Mio T: Small cell lung cancer transformation during
immunotherapy with nivolumab: A case report. Respir Med Case Rep.
21:52–55. 2017.PubMed/NCBI
|
15
|
Imakita T, Fujita K, Kanai O, Okamura M,
Hashimoto M, Nakatani K, Sawai S and Mio T: Small cell
transformation of non-small cell lung cancer under immunotherapy:
Case series and literature review. Thorac Cancer. 12:3062–3067.
2021. View Article : Google Scholar : PubMed/NCBI
|
16
|
Li Z, Hu J, Chen P and Zeng Z: Incidence,
treatment, and survival analysis in esophageal neuroendocrine
carcinoma population. Transl Cancer Res. 9:4317–4329. 2020.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Ho KJ, Herrera GA, Jones JM and Alexander
CB: Small cell carcinoma of the esophagus: Evidence for a unified
histogenesis. Hum Pathol. 15:460–468. 1984. View Article : Google Scholar : PubMed/NCBI
|
18
|
Yamasaki T, Ishii N, Okuno T, Suekane T,
Inoue T and Nebiki H: A case of esophageal squamous cell carcinoma
with neuroendocrine, basaloid, and ciliated glandular
differentiation. Clin J Gastroenterol. 14:32–38. 2021. View Article : Google Scholar : PubMed/NCBI
|
19
|
Robertson NJ, Rahamim J and Smith ME:
Carcinosarcoma of the oesophagus showing neuroendocrine, squamous
and glandular differentiation. Histopathology. 31:263–266. 1997.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Iwagami H, Uedo N and Kitamura M: Case of
esophageal superficial neuroendocrine carcinoma suggestive of
transformation from squamous cell carcinoma. Dig Endosc.
32:8272020. View Article : Google Scholar : PubMed/NCBI
|
21
|
Liu Z, Zhao Y, Kong P, Liu Y, Huang J, Xu
E, Wei W, Li G, Cheng X, Xue L, et al: Integrated multi-omics
profiling yields a clinically relevant molecular classification for
esophageal squamous cell carcinoma. Cancer Cell. 41:181–195.e9.
2023. View Article : Google Scholar : PubMed/NCBI
|